The revenue stream is obvious if you read their press releases and 10-Q's. Most of their income is from training courses they provide through their sub-company U.S. Stem Cell Training, products such as their special catheter that has shown to be better than Johnson and Johnson's comparable catheter, and providing stem cell treatments in their many international U.S. Stem Cell Clinics.